Skip to content
CityAM
Main navigation
Sign Up
  • News
    • Latest News
    • Property
    • Business
    • Media
    • Technology
    • Retail and leisure
    • Transport and infrastructure
    • Law & professional services
    • Legal Notices
    • Banking
    • Politics
    • CFA Institute Talk
    • ICAS Talk
    • Warwick Business School
    • The University of Bath
    • AON
  • Markets & Economics
    • Markets & Economics News
    • Economics
    • Markets
    • Schroders Talk
    • eToro Talk
    • IG Talk
    • M&A Talk
    • BCB Talk
  • Crypto A.M.
    • Crypto News
    • CoinCorner Talk
  • Opinion
    • Features
    • Letters
    • The City View
  • Jobs and Money
    • Jobs and Money News
    • Personal Development
    • Jobs
    • Fintech
    • Money
    • Personal Finance
    • Doceo
    • The Business Guide
    • 10 ways to run a more efficient business
    • Finance & Legal
  • Unwind
    • Unwind
    • Sport
    • Six Nations 2022
    • The Punter
    • The Punter Podcast
    • Culture
    • Life & Style
    • Sport Business
    • The Magazine
    • Travel
    • Discover Malta
    • Green Economy
    • The DiverCity Podcast
    • Aramco Team Series
    • Queen’s Award 2022
    • Health, Fitness, and Wellbeing
  • Charity
    • Giving
    • World’s biggest donors 2010 – 2021
  • Latest Paper
  • Jobs

Pharmaceuticals

  • UK competitions watchdog told to cover pharma firms’ costs after investigation failed

    Regulators

    The Supreme Court today said the UK’s Competition and Markets Authority (CMA) could be forced to cover Pfizer and Flynn Pharma’s legal costs, following the collapse of its case into the two pharmaceutical firms. The landmark ruling could see UK regulators made liable to pay the costs of those subject to failed investigations, after the [...]

  • Invidior unveils $100m share repurchase scheme with new drugs powering rebounding revenues

    BIG PAYOUT

    Invidior has announced a $100 plan to return capital to shareholders, with the pharmaceutical firm on track to achieve its full-year guidance.

  • Martin Shkreli’s lawyers ask to drop him as client as ‘pharma bro’ owes $2m in legal fees

    Pharma Bro

    Martin Shkreli’s lawyers are seeking to drop him as a client, over claims the price-hiking pharma exec owes them $2.04m (£1.57m). Philadelphia headquartered law firm Duane Morris LLP asked for a judge’s permission to pull out of representing Shkreli after claiming the imprisoned former hedge fund manager “has no assets” to pay its fees. The [...]

  • Oxford Nanopore Technology has spike in revenue but losses up more than £100m

    March 22, 2022

    A UK-based technology research firm has had spike in revenue by £30m, but an almost £100m loss from 2020. Oxford Nanopore Technologies, which develops state-of-the-art technology to analyse individual molecules, increased its intake to £134m in 2021, up from £114m. The company’s gross profit was up from 41 per cent to almost 55 per cent, [...]

  • J&J and three other drug distributors settle opioid crisis lawsuits for $26bn

    February 25, 2022

    US pharma giant Johnson & Johnson, and three of America’s largest medical distributors, have agreed to pay $26bn (£19bn) to settle more than 3,000 lawsuits over the role they played in fuelling America’s opioid crisis. New Jersey drugmaker J&J, and medicine distributors Cardinal Health, AmerisourceBergen, and Distributors McKesson, finalized a deal through which they will [...]

  • AIDS scientists cure human for the first time: Former HIV patient is off medication, asymptomatic and healthy

    February 16, 2022

    Researchers in the U.S. have said they have cured HIV in a human being for the very first time. The scientists said the mixed-race New York woman, who was previously HIV positive, was now “off medication, asymptomatic and healthy”, according to various media reports. The scientists reportedly used a cutting-edge stem cell transplant method that [...]

  • First patient in UK gets ‘vaccine’ for cancer that should help immune system ward off cancer permanently

    February 14, 2022

    A Merseyside man has become the first in the UK to receive a ‘vaccine’ that is hoped will stop his recurring head and neck cancer from returning, in a clinical research trial which may help bring further ground-breaking treatments for the disease. The clinical research team at The Clatterbridge Cancer Centre has given patient Graham [...]

  • Informa offloads Pharma Intelligence to Warburg Pincus for £1.9bn as firm shifts focus

    February 10, 2022

    Informa has agreed to sell Pharma Intelligence to US private equity group Warburg Pincus for £1.9bn, as the UK firm looks to boost shareholder value.

  • UK’s largest ever health research project is looking for 5 million Brits

    January 23, 2022

    A major health study which aims to predict who will get ill in their later years even before they show symptoms needs a record 5m volunteers. Hoped to be the UK’s largest ever health research programme, Our Future Health will track people throughout their lives in a bid to come up with new ways to [...]

  • France discovers new Covid variant IHU with 46 mutations amid 271,000 coronavirus infections, biggest one-day jump on record

    January 5, 2022

    French media are reporting that a new Covid variant with 46 mutations has been discovered in the country. The new strain, named IHU, has been discovered in the southwest of France and, according to multiple news outlets, intensive care and hospital admissions have been increasing in that region in recent days. So far, there are [...]

Posts navigation

  • Page 1
  • Page 2
  • Page 3
  • …
  • Page 10
  • Next

Trending Articles

  • PwC to give 11,000 workers their biggest pay rise in a decade

  • Graduates set to enter UK's strongest job market in years as starting salaries soar

  • Flying high: 10,000 UK jobs supported as BAE Systems cashes in with £500m order for Spanish fighter jets

  • Exclusive: Brits’ patience with Bank of England and Bailey wears thin amid historic inflation crunch

Subscribe

Subscribe to the City A.M. newsletter to have our top stories delivered directly to your inbox.

Subscribe
  • About us
  • Advertising
  • Contact
  • Terms & Conditions
  • Privacy Policy
  • News
  • Markets & Economics
  • Opinion
  • Jobs and Money
  • Unwind
  • Crypto A.M.
  • The Punter
  • COP 26
  • Awards 2019

Follow us for breaking news and latest updates

  • Newsletters
  • Latest paper
  • Advertising
  • CryptoAM.io
  • Awards
  • About
  • Tickets
Copyright 2022 City A.M. Limited